September 2015

Promising Results for Rituximab Treatment for Acquired Hemophilia A

January 20, 2016

Articles

Treating acquired hemophilia A (AHA) with anti CD20 monoclonal antibody Rituximab is increasingly popular, according to a case study published in the Mediterranean Journal of Hematology and Infectious Diseases.

x